Hiperplasia benigna de próstata: Cuantificación de síntornas, IPSS y valoración de la calidad de vida

Revista Clinica Espanola

Volumn 199, Issue SUPPL. 2, 1999, Pages 30-35

  Rodriguez Mora V L ^a   Vallejo, J M Rodríguez ^b   Alcázar, I García ^a   Gomez Acebo A ^a  

^a Servicio Medico   (Spain)

^b MSD España   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COMPARATIVE STUDY; HOSPITALIZATION; HUMAN; HYPERPLASIA; MALE; MIDDLE AGED; PATHOLOGY; PREVALENCE; PROSTATE; QUALITY OF LIFE; QUESTIONNAIRE;

AGED; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; PREVALENCE; PROSTATE; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 0033107858     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Boyle PR, Maisonneuve P, La Vecchia C. Epidemiology of benign prostatic hyperplasia: present knowledge and studies needed. Eur Urol 1991; 20 (suppl 2):3-10.
2. Arrighi HM, Metter EJ, Guess HA, Fozzard JL. Natural history of benign prostatic hyperplasia and risk of prostatectomy. Urology 1991; 38 (suppl):4-8.
3. Guess HA. Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin N Am 1995; 22:47-261.
4. Hald T, et al. Pathophysiology of the urinary bladder in obstruction and ageing. 4th International Consultation on Bening Prostatic Hyperplasia, 1998; 131-178.
5. Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC, and the Writing Committee. Transurethral prostatectomy: inmediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989; 141:243-247.
6. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett ATK, and the AUA Measurement Committee. The American Urological Association Symptom Index for benign prostatic hyperplasia. J Urol 1992; 148:1.549-1.557.
7. Vela Navarrete R, et al. Prostatismo en España: perfil clínico del paciente solicitando tratamiento al urólogo. Actas Urológicas Españolas 1998; 5 (suppl 22):24.
8. Vela Navarrete R, Martín Moreno JM, Damián Moreno J, Hernández-Coronado Carpio A, Calahorra Fernández FJ, Boyle P. Baremo internacional de sintomatología prostática. Actas Urológicas Españolas 1994; XVIII:8.
9. Cochett AT, Aso Y, Denis L, Murphy G, Khoury S, Abrams P, and numbers of the comitees. Recomendations of the International Consensus Committee (ICC) under the patronage of the World Health Organization (WHO): the second international consultation of benign prostatic hyperplasia, 1994; 635-647.
10. a ed). Consejo Nacional de la Salud Prostática, 1993; 131-155.
11. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, Lieber MM. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 1993; 150:85-89.
12. Salo JO, Rannikko T, Makinen J, Lehtonen T. Echogenic structure of prostatic cancer imaged on radical prostatectomy specimens. Prostate 1987; 10:1-9.
13. Dahnert W, Hamper V, Eggleston J, et al. Prostatic evaluation by transrectal sonography with histopathologic correlation: the echonegenic appearance of early carcinoma. Radiology 1986; 158:97-102.
14. Álvarez Cáceres R. Estadistica multivariante y no paramétrica. Madrid: Díaz de Santos, 1996; 32.
15. Lee AJ, Garraway WM, et al. Natural history of untreated lower urinary tract symptons in middle-age and elderly men over a period of five years. European Urology 1998; 34:325-332.
16. a ed) 1997; 3-8.
17. Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991; 338:469-471.
18. Epstein RS, Deverka PA, Chute CG, et al. Urinary symptoms and quality of life question indicative of obstructive benign prostatic hyperplasia. Result of pilot study. Urology 1991 (suppl 1);38:20.
19. Tsang KK, Garraway WM. Impact of benign prostatic hyperplasia on general well-being of men. Prostate 1993; 23:1-7.
20. Girman CJ, et al. Natural history of prostatism: urinary flow rates in a community-based study. J Urol 1993; 150:887-892.
21. Tsukamoto T, et al. Japanese men have lower increase in prostate growth and greater decrease in peak urinary flow rate with age than American men. Proceedings of the American Urological Association, 1995; suppl 477A:153.